Cargando…

Cancer chemotherapy induces cardiotoxicity by targeting cardiac stem cells

Overwhelming data indicate that cancer survivors are at higher risk of cardiovascular diseases because chemotherapy induces cardiotoxicity. Mechanistic explanation of this phenomenon is necessary to advise the clinical practice on the prevention of cardiotoxicity in cancer patients. Here we propose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yong-mei, Guo, Yue-ping, Liu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373483/ https://www.ncbi.nlm.nih.gov/pubmed/20874720 http://dx.doi.org/10.1111/j.1582-4934.2010.01177.x

Ejemplares similares

Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention
por: CSAPO, MELINDA, et al.
Publicado: (2014)

Premature Cardiac Senescence: An Unsung Hero in Chemotherapy-Induced Cardiotoxicity?
por: Meléndez, Giselle C., et al.
Publicado: (2023)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
por: Briasoulis, Alexandros, et al.
Publicado: (2022)

The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity
por: Sorodoc, Victorita, et al.
Publicado: (2022)

Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
por: Angsutararux, Paweorn, et al.
Publicado: (2015)

Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
por: Cai, Fengfeng, et al.
Publicado: (2019)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
por: Viswanathan, Thyla, et al.
Publicado: (2021)

Reintroduction of 5-Fluorouracil Post-cardiac Arrest Secondary to Chemotherapy-Induced Cardiotoxicity
por: Wu, Kathie, et al.
Publicado: (2023)

Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity
por: Yang, Xinyu, et al.
Publicado: (2020)

The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

Cardiac Sympathetic Hyperactivity after Chemotherapy: Early Sign of Cardiotoxicity?
por: Guimarães, Sarita Lígia Pessoa de Melo Machado, et al.
Publicado: (2015)

Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
por: Wu, Bin Bin, et al.
Publicado: (2022)

Aging, cardiotoxicity, and chemotherapy
por: Bocchi, Edimar Alcides, et al.
Publicado: (2019)

Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
por: Radulescu, Liliana Maria, et al.
Publicado: (2021)

Chemotherapy-Induced Cardiotoxicity: Subclinical Cardiac Dysfunction Evidence Using Speckle Tracking Echocardiography
por: Monte, Ines, et al.
Publicado: (2013)

Editorial: Cardiotoxicity induced by radiotherapy and/or chemotherapy after cancer treatment
por: Boerma, Marjan, et al.
Publicado: (2022)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation
por: Rahman, Atiar M, et al.
Publicado: (2007)

Cardiotoxicity in cancer patients treated with chemotherapy: A systematic review
por: Lima, Maria Adriely Cunha, et al.
Publicado: (2022)

Pediatric Anthracycline‐Induced Cardiotoxicity: Mechanisms, Pharmacogenomics, and Pluripotent Stem‐Cell Modeling
por: Tripaydonis, Anne, et al.
Publicado: (2019)

Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Huang, Mo-Fan, et al.
Publicado: (2021)

Physiopathology and diagnosis of cardiotoxicity in patients submitted to chemotherapy treatment
por: Marmelo, Filipe C., et al.
Publicado: (2019)

Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
por: Khattry, Navin, et al.
Publicado: (2009)

Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity
por: Legi, Ashiq, et al.
Publicado: (2021)

Cardiotoxicity of anthracycline-free targeted oncological therapies in HER2-positive breast cancer
por: Guan, Jingyuan, et al.
Publicado: (2021)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs
por: Adamcova, Michaela, et al.
Publicado: (2019)

Protective role of beta-blockers in chemotherapy-induced cardiotoxicity—a systematic review and meta-analysis of carvedilol
por: Huang, Shan, et al.
Publicado: (2018)

MicroRNAs in Cancer Treatment-Induced Cardiotoxicity
por: Pellegrini, Laura, et al.
Publicado: (2020)

Doxorubicin cardiotoxicity and target cells: a broader perspective
por: De Angelis, Antonella, et al.
Publicado: (2016)

Cardiac Nonmyocyte Cell Functions and Crosstalks in Response to Cardiotoxic Drugs
por: Gambardella, Jessica, et al.
Publicado: (2017)

ICIs-Related Cardiotoxicity in Different Types of Cancer
por: Dong, Mei, et al.
Publicado: (2022)

Oxidative Stress in Radiation-Induced Cardiotoxicity
por: Ping, Zhang, et al.
Publicado: (2020)

Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study
por: Gavila, J., et al.
Publicado: (2016)

Evaluation of early subclinical cardiotoxicity of chemotherapy in breast cancer
por: Alıcı, Hayri, et al.
Publicado: (2015)

Cardiotoxicity of Novel Targeted Hematological Therapies
por: Giudice, Valentina, et al.
Publicado: (2020)

Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death
por: Kong, Chun-Yan, et al.
Publicado: (2022)

H(2)S Donors with Cytoprotective Effects in Models of MI/R Injury and Chemotherapy-Induced Cardiotoxicity
por: Hu, Qiwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vmuiqksbfish7k1j8rii9t0agv